Typing the atypical: Diagnostic issues and predictive markers in suspicious prostate lesions

References

• Serag H, Banerjee S, Saeb-Parsy K, et al. Risk profiles of prostate cancers identified from UK primary care using national referral guidelines. Br J Cancer. 2012;106:436–439.
   PubMed Web of Science ®Google Scholar
• Bostwick DG, Srigley J, Grignon D, et al. Atypical adenomatous hyperplasia of the prostate: morphologic criteria for its distinction from well-differentiated carcinoma. Hum Pathol. 1993;24:819–832.
   PubMed Web of Science ®Google Scholar
• Iczkowski KA, MacLennan GT, Bostwick DG. Atypical small acinar proliferation suspicious for malignancy in prostate needle biopsies: clinical significance in 33 cases. Am J Surg Pathol. 1997;21:1489–1495.
   PubMed Web of Science ®Google Scholar
• Cheville JC, Reznicek MJ, Bostwick DG. The focus of “atypical glands” suspicious for malignancy in prostate needle biopsy specimens: incidence, histologic features, and clinical follow-up of cases diagnosed in a community practice. Am J Clin Pathol. 1997;108:633–640.
   PubMed Web of Science ®Google Scholar
• Helpap B. Differential diagnosis of glandular proliferations in the prostate. A conventional and immunohistochemical approach. Virchows Arch. 1998;433:397–405.
   PubMed Web of Science ®Google Scholar
• Borboroglu PG, Sur RL, Roberts JL, et al. Repeat biopsy strategy in patients with atypical small acinar proliferation or high grade prostatic intraepithelial neoplasia on initial prostate needle biopsy. J Urol. 2001;166:866–870.
   PubMed Web of Science ®Google Scholar
• Ouyang RC, Kenwright DN, Nacey JN, et al. The presence of atypical small acinar proliferation in prostate needle biopsy is predictive of carcinoma on subsequent biopsy. BJU Int. 2001;87:70–74.
   PubMed Web of Science ®Google Scholar
• Iczkowski KA, Chen HM, Yang XJ, et al. Prostate cancer diagnosed after initial biopsy with atypical small acinar proliferation suspicious for malignancy is similar to cancer found on initial biopsy. Urology. 2002;60:851–854.
   PubMed Web of Science ®Google Scholar
• Epstein JI. Atypical small acinar proliferation of the prostate gland [letter]. Am J Surg Pathol. 1998;22:1430–1431.
   PubMed Web of Science ®Google Scholar
• Epstein JI. How should atypical prostate needle biopsies be reported? Controversies regarding the term “ASAP”. Hum Pathol. 1999;30:1401–1402.
   PubMed Web of Science ®Google Scholar
• Murphy WM. ASAP is a bad idea. Atypical small acinar proliferation. Hum Pathol. 1999;30:601.
   PubMed Web of Science ®Google Scholar
• Boccon-Gibod L, van der Kwast TH, Montironi R, et al. Handling and pathology reporting of prostate biopsies. Eur Urol. 2004;46:177–181.
   PubMed Web of Science ®Google Scholar
• Amin M, Boccon-Gibod L, Egevad L, et al. Prognostic and predictive factors and reporting of prostate carcinoma in prostate needle biopsy specimens. Scand J Urol Nephrol Suppl. 2005;39:20–33.
   Google Scholar
• van der Kwast TH, Lopes C, Santonja C, et al. Guidelines for processing and reporting of prostatic needle biopsies. J Clin Pathol. 2003;56:336–340.
   PubMed Web of Science ®Google Scholar
• Epstein JI, Potter SR. The pathological interpretation and significance of prostate needle biopsy findings: implications and current controversies. J Urol. 2001;166:402–410.
   PubMed Web of Science ®Google Scholar
• Epstein JI. Diagnosis and reporting of limited adenocarcinoma of the prostate on needle biopsy. Mod Pathol. 2004;17:307–315.
   PubMed Web of Science ®Google Scholar
• World Health Organization Classification of Tumours. Pathology and genetics of tumours of the urinary system and male genital organs. In: Eble JN, Sauter G, Epstein JI, Sesterhenn IA, editors. Lyon: IARC Press, 2004.
   Google Scholar
• Egevad L, Allsbrook WC, Epstein JI. Current practice of diagnosis and reporting of prostatic intraepithelial neoplasia and glandular atypia among genitourinary pathologists. Mod Pathol. 2006;19:180–185.
   PubMed Web of Science ®Google Scholar
• Epstein JI, Herawi M. Prostate needle biopsies containing prostatic intraepithelial neoplasia or atypical foci suspicious for carcinoma: implications for patient care. J Urol. 2006;176:820–834.
   Web of Science ®Google Scholar
• Bostwick DG, Meiers I. Atypical small acinar proliferation in the prostate: clinical significance in 2006. Arch Pathol Lab Med. 2006;130:952–957.
   PubMed Web of Science ®Google Scholar
• Iczkowski KA. Current prostate biopsy interpretation: criteria for cancer, atypical small acinar proliferation, high-grade prostatic intraepithelial neoplasia, and use of immunostains. Arch Pathol Lab Med. 2006;130:835–843.
   PubMed Web of Science ®Google Scholar
• Fadare O, Wang S, Mariappan MR. Practice patterns of clinicians following isolated diagnoses of atypical small acinar proliferation on prostate biopsy specimens. Arch Pathol Lab Med. 2004;128:557–560.
   PubMed Web of Science ®Google Scholar
• Mottet N, Bellmunt J, Briers E, et al. EAU-ESTRO-SIOG guidelines on prostate cancer. Eur Assoc Urol. 2016.
   Google Scholar
• Gupta C, Ren JZ, Wojno KJ. Individual submission and embedding of prostate biopsies decreases rates of equivocal pathology reports. Urology. 2004;63:83–86.
   PubMed Web of Science ®Google Scholar
• Rogatsch H, Moser P, Volgger H, et al. Diagnostic effect of an improved preembedding method of prostate needle biopsy specimens. Hum Pathol. 2000;31:1102–1107.
   PubMed Web of Science ®Google Scholar
• Montironi R, Lopez-Beltran A, Mazzucchelli R, et al. Contemporary update on pathology-related issues on routine workup of prostate biopsy: sectioning, tumor extent measurement, specimen orientation, and immunohistochemistry. Anal Quant Cytopathol Histpathol. 2014;36:61–70.
   PubMed Web of Science ®Google Scholar
• Renshaw AA. Adequate tissue sampling of prostate core needle biopsies. Am J Clin Pathol. 1997;107:26–29.
   PubMed Web of Science ®Google Scholar
• Novis DA, Zarbo RJ, Valenstein PA. Diagnostic uncertainty expressed in prostate needle biopsies. A College of American Pathologists Q-probes Study of 15,753 prostate needle biopsies in 332 institutions. Arch Pathol Lab Med. 1999;123:687–692.
   PubMed Web of Science ®Google Scholar
• Reyes AO, Humphrey PA. Diagnostic effect of complete histologic sampling of prostate needle biopsy specimens. Am J Clin Pathol. 1998;109:416–422.
   PubMed Web of Science ®Google Scholar
• Brat DJ, Wills ML, Lecksell KL, et al. How often are diagnostic features missed with less extensive histologic sampling of prostate needle biopsy specimens? Am J Surg Pathol. 1999;23:257–262.
   PubMed Web of Science ®Google Scholar
• Thorson P, Humphrey PA. Minimal adenocarcinoma in prostate needle biopsy tissue. Am J Clin Pathol. 2000;114:896–909.
   PubMed Web of Science ®Google Scholar
• Arista-Nasr J, Martinez-Mijangos O, Martinez-Benitez B. [Utility of additional histological sections on prostatic needle biopsies with focal glandular atypia]. Actas Urol Esp. 2008;32:594–598.
   PubMed Web of Science ®Google Scholar
• Arista-Nasr J, Martinez-Mijangos O, Martinez-Benitez B, et al. Atypical small acinar proliferation: utility of additional sections and immunohistochemical analysis of prostatic needle biopsies. Nephro Urol Mon. 2012;4:443–447.
   PubMedGoogle Scholar
• Arista-Nasr J, de Anda-Gonzalez J, Bornstein-Quevedo L, et al. [Utility of seriated sections in prostate biopsies]. Actas Urol Esp. 2012;36:578–582.
   PubMed Web of Science ®Google Scholar
• Arista-Nasr J, Keirns C. The focus of atypical glands, suspicious for malignancy in prostatic needle biopsy specimens”. Am J Clin Pathol. 1998;110:409.
   PubMed Web of Science ®Google Scholar
• Flury SC, Galgano MT, Mills SE, et al. Atypical small acinar proliferation: biopsy artefact or distinct pathological entity? BJU Int. 2007;99:780–785.
   PubMed Web of Science ®Google Scholar
• Iczkowski KA, Bassler TJ, Schwob VS, et al. Diagnosis of suspicious for malignancy in prostate biopsies: predictive value for cancer. Urology. 1998;51:749–757.
   PubMed Web of Science ®Google Scholar
• Hameed O, Humphrey PA. Immunohistochemical evaluation of prostate needle biopsies using saved interval sections vs new recut sections from the block: a prospective comparison. Am J Clin Pathol. 2009;131:683–687.
   PubMed Web of Science ®Google Scholar
• Dickinson SI. Premalignant and malignant prostate lesions: pathologic review. Cancer Control. 2010;17:214–222.
   PubMed Web of Science ®Google Scholar
• Alvarez-Alvarez C, Silva EA, Pesqueira D, et al. Atypical small glands in prostate needle biopsies. Diagnostic value of clinicopathological parameters. Braz J Urol. 2000;26:503–509.
   Google Scholar
• Green R, Epstein JI. Use of intervening unstained slides for immunohistochemical stains for high molecular weight cytokeratin on prostate needle biopsies. Am J Surg Pathol. 1999;23:567–570.
   PubMed Web of Science ®Google Scholar
• Wojno KJ, Epstein JI. The utility of basal cell-specific anti-cytokeratin antibody (34 beta E12) in the diagnosis of prostate cancer. A review of 228 cases . Am J Surg Pathol. 1995;19:251–260.
   PubMed Web of Science ®Google Scholar
• Strand CL, Aponte SL, Chatterjee M, et al. Improved resolution of diagnostic problems in selected prostate needle biopsy specimens by using the ASAP workup: a prospective study of interval sections vs new recut sections. Am J Clin Pathol. 2010;134:293–298.
   PubMed Web of Science ®Google Scholar
• Iczkowski KA, Bostwick DG. Criteria for biopsy diagnosis of minimal volume prostatic adenocarcinoma: analytic comparison with nondiagnostic but suspicious atypical small acinar proliferation. Arch Pathol Lab Med. 2000;124:98–107.
   PubMed Web of Science ®Google Scholar
• Cavalcanti Fde B, Alves VA, Pereira J, et al. Proliferative lesions of prostate: a multivariate approach to differential diagnosis. Pathol Oncol Res. 2005;11:103–107.
   PubMed Web of Science ®Google Scholar
• Gilbert ES. On discrimination using qualitative variables. J Am Stat Assoc. 1968;63:1399–1412.
   Web of Science ®Google Scholar
• Varma M, Lee MW, Tamboli P, et al. Morphologic criteria for the diagnosis of prostatic adenocarcinoma in needle biopsy specimens. A study of 250 consecutive cases in a routine surgical pathology practice. Arch Pathol Lab Med. 2002;126:554–561.
   PubMed Web of Science ®Google Scholar
• Epstein JI. Diagnostic criteria of limited adenocarcinoma of the prostate on needle biopsy. Hum Pathol. 1995;26:223–229.
   PubMed Web of Science ®Google Scholar
• Thorson P, Vollmer RT, Arcangeli C, et al. Minimal carcinoma in prostate needle biopsy specimens: diagnostic features and radical prostatectomy follow-up. Mod Pathol. 1998;11:543–551.
   PubMed Web of Science ®Google Scholar
• Ro JY, Grignon DJ, Troncoso P, et al. Mucin in prostatic adenocarcinoma. Semin Diagn Pathol. 1988;5:273–283.
   PubMed Web of Science ®Google Scholar
• Goldstein NS, Qian J, Bostwick DG. Mucin expression in atypical adenomatous hyperplasia of the prostate. Hum Pathol. 1995;26:887–891.
   PubMed Web of Science ®Google Scholar
• Orozco R, Kunnel B, Carabajal J, et al. Prostate cancer detection rate of biopsies done after three nonpositive attempts [abstract]. Am J Clin Pathol. 1997;108:337.
   Google Scholar
• Oppenheimer JR, Wills ML, Epstein JI. Partial atrophy in prostate needle cores: another diagnostic pitfall for The Surgical Pathologist. Am J Surg Pathol. 1998;22:440–445.
   PubMed Web of Science ®Google Scholar
• Anton RC, Chakraborty S, Wheeler TM. The significance of intraluminal prostatic crystalloids in benign needle biopsies. Am J Surg Pathol. 1998;22:446–449.
   PubMed Web of Science ®Google Scholar
• Del Rosario AD, Bui HX, Abdulla M, et al. Sulfur-rich prostatic intraluminal crystalloids: a surgical pathologic and electron probe X-ray microanalytic study. Hum Pathol. 1993;24:1159–1167.
   PubMed Web of Science ®Google Scholar
• Henneberry JM, Kahane H, Humphrey PA, et al. The significance of intraluminal crystalloids in benign prostatic glands on needle biopsy. Am J Surg Pathol. 1997;21:725–728.
   PubMed Web of Science ®Google Scholar
• Bostwick DG, Wollan P, Adlakha K. Collagenous micronodules in prostate cancer. A specific but infrequent diagnostic finding. Arch Pathol Lab Med. 1995;119:444–447.
   PubMed Web of Science ®Google Scholar
• Chan TY, Epstein JI. Follow-up of atypical prostate needle biopsies suspicious for cancer. Urology. 1999;53:351–355.
   PubMed Web of Science ®Google Scholar
• Wills ML, Hamper UM, Partin AW, et al. Incidence of high-grade prostatic intraepithelial neoplasia in sextant needle biopsy specimens. Urology. 1997;49:367–373.
   PubMed Web of Science ®Google Scholar
• Van der Kwast TH, Evans A, Lockwood G, et al. Variability in diagnostic opinion among pathologists for single small atypical foci in prostate biopsies. Am J Surg Pathol. 2010;34:169–177.
   PubMed Web of Science ®Google Scholar
• Chen S, Patil PA, Lepe M, et al. Retrospective analysis of atypical glands suspicious for carcinoma in transurethral resection of prostate. Appl Immunohistochem Mol Morphol. 2016. DOI:10.1097/PAI.0000000000000407
   Google Scholar
• Allen EA, Kahane H, Epstein JI. Repeat biopsy strategies for men with atypical diagnoses on initial prostate needle biopsy. Urology. 1998;52:803–807.
   PubMed Web of Science ®Google Scholar
• Samaratunga H, Gardiner RA, Yaxley J, et al. Atypical prostatic glandular proliferation on needle biopsy: diagnostic implications, use of immunohistochemistry, and clinical significance. Anal Quant Cytol Histol. 2006;28:104–110.
   PubMed Web of Science ®Google Scholar
• Abouassaly R, Tan N, Moussa A, et al. Risk of prostate cancer after diagnosis of atypical glands suspicious for carcinoma on saturation and traditional biopsies. J Urol. 2008;180:911–914.
   PubMed Web of Science ®Google Scholar
• Gaudin PB, Epstein JI. Adenosis of the prostate. Histologic features in needle biopsy specimens. Am J Surg Pathol. 1995;19:737–747.
   PubMed Web of Science ®Google Scholar
• Herawi M, Parwani T, Irie J, et al. Small glandular proliferations on needle biopsies: most common benign mimickers of prostatic adenocarcinoma sent in for expert second opinion. Am J Surg Pathol. 2005;29:874–880.
   PubMed Web of Science ®Google Scholar
• Srigley JR. Small-acinar patterns in the prostate gland with emphasis on atypical adenomatous hyperplasia and small-acinar carcinoma. Semin Diagn Pathol. 1988;5:254–272.
   PubMed Web of Science ®Google Scholar
• Amin MB. Florid hyperplasia of mesonephric remnants: yet another differential diagnostic consideration under “small acinar proliferations of the prostate”. Adv Anat Pathol. 1995;2:108–113.
   Google Scholar
• Montironi R, Vela-Navarrete R, Lopez-Beltran A, et al. 2005 update on pathology of prostate biopsies with cancer. Eur Urol. 2006;49:441–447.
   PubMed Web of Science ®Google Scholar
• Helpap B, Kollermann J, Oehler U. Limiting the diagnosis of atypical small glandular proliferations in needle biopsies of the prostate by the use of immunohistochemistry. J Pathol. 2001;193:350–353.
   PubMed Web of Science ®Google Scholar
• Varma M, Linden MD, Amin MB. Effect of formalin fixation and epitope retrieval techniques on antibody 34betaE12 immunostaining of prostatic tissues. Mod Pathol. 1999;12:472–478.
   PubMed Web of Science ®Google Scholar
• Kahane H, Sharp JW, Shuman GB, et al. Utilization of high molecular weight cytokeratin on prostate needle biopsies in an independent laboratory. Urology. 1995;45:981–986.
   PubMed Web of Science ®Google Scholar
• Tran TA, Ayala AG, Amin MB. Utility of high-molecular weight Cytokeratin 34βE12 in atypical small acinar proliferations in prostatic needle biopsies. Appl Immunohistochem Mol Morphol. 1999;7:186–192.
   Google Scholar
• Yang XJ, Lecksell K, Gaudin P, et al. Rare expression of high-molecular-weight cytokeratin in adenocarcinoma of the prostate gland: a study of 100 cases of metastatic and locally advanced prostate cancer. Am J Surg Pathol. 1999;23:147–152.
   PubMed Web of Science ®Google Scholar
• Oliai BR, Kahane H, Epstein JI. Can basal cells be seen in adenocarcinoma of the prostate?: an immunohistochemical study using high molecular weight cytokeratin (clone 34betaE12) antibody. Am J Surg Pathol. 2002;26:1151–1160.
   PubMed Web of Science ®Google Scholar
• Shah RB, Zhou M, LeBlanc M, et al. Comparison of the basal cell-specific markers, 34betaE12 and p63, in the diagnosis of prostate cancer. Am J Surg Pathol. 2002;26:1161–1168.
   PubMed Web of Science ®Google Scholar
• Varma M, Jasani B. Diagnostic utility of immunohistochemistry in morphologically difficult prostate cancer: review of current literature. Histopathology. 2005;47:1–16.
   PubMed Web of Science ®Google Scholar
• Skinnider BF, Oliva E, Young RH, et al. Expression of alpha-methylacyl-CoA racemase (P504S) in nephrogenic adenoma: a significant immunohistochemical pitfall compounding the differential diagnosis with prostatic adenocarcinoma. Am J Surg Pathol. 2004;28:701–705.
   PubMed Web of Science ®Google Scholar
• Sanderson SO, Sebo TJ, Murphy LM, et al. An analysis of the p63/alpha-methylacyl coenzyme A racemase immunohistochemical cocktail stain in prostate needle biopsy specimens and tissue microarrays. Am J Clin Pathol. 2004;121:220–225.
   PubMed Web of Science ®Google Scholar
• Abrahams NA, Ormsby AH, Brainard J. Validation of cytokeratin 5/6 as an effective substitute for keratin 903 in the differentiation of benign from malignant glands in prostate needle biopsies. Histopathology. 2002;41:35–41.
   PubMed Web of Science ®Google Scholar
• Molinié V, Fromont G, Sibony M, et al. Diagnostic utility of a p63/alpha-methyl-CoA-racemase (p504s) cocktail in atypical foci in the prostate. Mod Pathol. 2004;17:1180–1190.
   PubMed Web of Science ®Google Scholar
• Parsons JK, Gage WR, Nelson WG, et al. p63 protein expression is rare in prostate adenocarcinoma: implications for cancer diagnosis and carcinogenesis. Urology. 2001;58:619–624.
   PubMed Web of Science ®Google Scholar
• Zhou M, Jiang Z, Epstein JI. Expression and diagnostic utility of alpha-methylacyl-CoA-racemase (P504S) in foamy gland and pseudohyperplastic prostate cancer. Am J Surg Pathol. 2003;27:772–778.
   PubMed Web of Science ®Google Scholar
• Zhou M, Chinnaiyan AM, Kleer CG, et al. Alpha-Methylacyl-CoA racemase: a novel tumor marker over-expressed in several human cancers and their precursor lesions. Am J Surg Pathol. 2002;26:926–931.
   PubMed Web of Science ®Google Scholar
• Weinstein MH, Signoretti S, Loda M. Diagnostic utility of immunohistochemical staining for p63, a sensitive marker of prostatic basal cells. Mod Pathol. 2002;15:1302–1308.
   PubMed Web of Science ®Google Scholar
• Ahmed NS, Abu-Zeid RM, Cousha HS, et al. Immunohistochemical expression of P63 and α-methylacyl-coenzyme A racemase (P504S) in benign, atypical, and malignant prostatic lesions. Egypt J Pathol. 2011;31:54–61.
   Google Scholar
• Paner GP, Luthringer DJ, Amin MB. Best practice in diagnostic immunohistochemistry: prostate carcinoma and its mimics in needle core biopsies. Arch Pathol Lab Med. 2008;132:1388–1396.
   PubMed Web of Science ®Google Scholar
• Kuroda N, Katto K, Tamura M, et al. Immunohistochemical application of D2-40 as basal cell marker in evaluating atypical small acinar proliferation of initial routine prostatic needle biopsy materials. Med Mol Morphol. 2010;43:165–169.
   PubMed Web of Science ®Google Scholar
• Adley BP, Yang XJ. Application of alpha-methylacyl coenzyme A racemase immunohistochemistry in the diagnosis of prostate cancer: a review. Anal Quant Cytol Histol. 2006;28:1–13.
   PubMed Web of Science ®Google Scholar
• Jiang Z, Wu CL, Woda BA, et al. Alpha-methylacyl-CoA racemase: a multi-institutional study of a new prostate cancer marker. Histopathology. 2004;45:218–225.
   PubMed Web of Science ®Google Scholar
• Zhou M, Aydin H, Kanane H, et al. How often does alpha-methylacyl-CoA-racemase contribute to resolving an atypical diagnosis on prostate needle biopsy beyond that provided by basal cell markers? Am J Surg Pathol. 2004;28:239–243.
   PubMed Web of Science ®Google Scholar
• Jiang Z, Woda BA, Rock KL, et al. P504S: a new molecular marker for the detection of prostate carcinoma. Am J Surg Pathol. 2001;25:1397–1404.
   PubMed Web of Science ®Google Scholar
• Jiang Z, Woda BA, Wu CL, et al. Discovery and clinical application of a novel prostate cancer marker: alpha-methylacyl CoA racemase (P504S) ). Am J Clin Pathol. 2004;122:275–289.
   PubMed Web of Science ®Google Scholar
• Harvey AM, Grice B, Hamilton C, et al. Diagnostic utility of P504S/p63 cocktail, prostate-specific antigen, and prostatic acid phosphatase in verifying prostatic carcinoma involvement in seminal vesicles: a study of 57 cases of radical prostatectomy specimens of pathologic stage pT3b. Arch Pathol Lab Med. 2010;134:983–988.
   PubMed Web of Science ®Google Scholar
• Yang XJ, Wu CL, Woda BA, et al. Expression of alpha-Methylacyl-CoA racemase (P504S) in atypical adenomatous hyperplasia of the prostate. Am J Surg Pathol. 2002;26:921–925.
   PubMed Web of Science ®Google Scholar
• Gupta A, Wang HL, Policarpio-Nicolas ML, et al. Expression of alpha-methylacyl-coenzyme A racemase in nephrogenic adenoma. Am J Surg Pathol. 2004;28:1224–1229.
   PubMed Web of Science ®Google Scholar
• Magi-Galluzzi C, Luo J, Isaacs WB, et al. Alpha-methylacyl-CoA racemase: a variably sensitive immunohistochemical marker for the diagnosis of small prostate cancer foci on needle biopsy. Am J Surg Pathol. 2003;27:1128–1133.
   PubMed Web of Science ®Google Scholar
• Singh V, Manu V, Malik A, et al. Diagnostic utility of p63 and α-methyl acyl Co A racemase in resolving suspicious foci in prostatic needle biopsy and transurethral resection of prostate specimens. J Cancer Res Ther. 2014;10:686–692.
   PubMed Web of Science ®Google Scholar
• Sanguedolce F, Cormio A, Brunelli M, et al. Urine TMPRSS2:ERG fusion transcript as a biomarker for prostate cancer: literature review. Clin Genitourin Cancer. 2016;14:117–121.
   PubMed Web of Science ®Google Scholar
• Shah RB, Tadros Y, Brummell B, et al. The diagnostic use of ERG in resolving an “atypical glands suspicious for cancer” diagnosis in prostate biopsies beyond that provided by basal cell and α-methylacyl-CoA-racemase markers. Hum Pathol. 2013;44:786–794.
   PubMed Web of Science ®Google Scholar
• Mehra R, Han B, Tomlins SA, et al. Heterogeneity of TMPRSS2 gene rearrangements in multifocal prostate adenocarcinoma: molecular evidence for an independent group of diseases. Cancer Res. 2007;67:7991–7995.
   PubMed Web of Science ®Google Scholar
• Tomlins SA, Palanisamy N, Siddiqui J, et al. Antibody-based detection of ERG rearrangements in prostate core biopsies, including diagnostically challenging cases: ERG staining in prostate core biopsies. Arch Pathol Lab Med. 2012;136:935–946.
   PubMed Web of Science ®Google Scholar
• Zhou M, Shah R, Shen R, et al. Basal cell cocktail (34betaE12 + p63) improves the detection of prostate basal cells. Am J Surg Pathol. 2003;27:365–371.
   PubMed Web of Science ®Google Scholar
• Jiang Z, Li C, Fischer A, et al. Using an AMACR (P504S)/34betaE12/p63 cocktail for the detection of small focal prostate carcinoma in needle biopsy specimens. Am J Clin Pathol. 2005;123:231–236.
   PubMed Web of Science ®Google Scholar
• Jiang Z, Fanger GR, Woda BA, et al. Expression of alpha-methylacyl-CoA racemase (P504s) in various malignant neoplasms and normal tissues: a study of 761 cases. Hum Pathol. 2003;34:792–796.
   PubMed Web of Science ®Google Scholar
• Hameed O, Sublett J, Humphrey PA. Immunohistochemical stains for p63 and alpha-methylacyl-CoA racemase, versus a cocktail comprising both, in the diagnosis of prostatic carcinoma: a comparison of the immunohistochemical staining of 430 foci in radical prostatectomy and needle biopsy tissues. Am J Surg Pathol. 2005;29:579–587.
   PubMed Web of Science ®Google Scholar
• Scattoni V, Roscigno M, Freschi M, et al. Predictors of prostate cancer after initial diagnosis of atypical small acinar proliferation at 10 to 12 core biopsies. Urology. 2005;66:1043–1047.
   PubMed Web of Science ®Google Scholar
• Jiang Z, Iczkowski KA, Woda BA, et al. P504S immunostaining boosts diagnostic resolution of suspicious foci in prostatic needle biopsy specimens. Am J Clin Pathol. 2004;121:99–107.
   PubMed Web of Science ®Google Scholar
• Yaskiv O, Zhang X, Simmerman K, et al. The utility of ERG/P63 double immunohistochemical staining in the diagnosis of limited cancer in prostate needle biopsies. Am J Surg Pathol. 2011;35:1062–1068.
   PubMed Web of Science ®Google Scholar
• Ng VW, Koh M, Tan SY, et al. Is triple immunostaining with 34betaE12, p63, and racemase in prostate cancer advantageous? A tissue microarray study. Am J Clin Pathol. 2007;127:248–253.
   PubMed Web of Science ®Google Scholar
• Epstein JI, Grignon DJ, Humphrey PA, et al. Interobserver reproducibility in the diagnosis of prostatic intraepithelial neoplasia. Am J Surg Pathol. 1995;19:873–886.
   PubMed Web of Science ®Google Scholar
• Allam CK, Bostwick DG, Hayes JA, et al. Interobserver variability in the diagnosis of high-grade prostatic intraepithelial neoplasia and adenocarcinoma. Mod Pathol. 1996;9:742–751.
   PubMed Web of Science ®Google Scholar
• Renshaw AA, Santis WF, Richie JP. Clinicopathological characteristics of prostatic adenocarcinoma in men with atypical prostate needle biopsies. J Urol. 1998;159:2018–2021.
   PubMed Web of Science ®Google Scholar
• Lopez JI. Prostate adenocarcinoma detected after high-grade prostatic intraepithelial neoplasia or atypical small acinar proliferation. BJU Int. 2007;100:1272–1276.
   PubMed Web of Science ®Google Scholar
• Brausi M, Castagnetti G, Dotti A, et al. Immediate radical prostatectomy in patients with atypical small acinar proliferation. over treatment? J Urol. 2004;172:906–908.
   PubMed Web of Science ®Google Scholar
• Shah RB, Leandro G, Romerocaces G, et al. Improvement of diagnostic agreement among pathologists in resolving an “atypical glands suspicious for cancer” diagnosis in prostate biopsies utilizing a novel “Disease-Focused Diagnostic Review” quality improvement process. Hum Pathol. 2016;56:155–162.
   PubMed Web of Science ®Google Scholar
• Roehrborn CG, Pickens GJ, Sanders JS. Diagnostic yield of repeated transrectal ultrasound-guided biopsies stratified by specific histopathologic diagnoses and prostate specific antigen levels. Urology. 1996;47:347–352.
   PubMed Web of Science ®Google Scholar
• Alsikafi NF, Brendler CB, Gerber GS, et al. High-grade prostatic intraepithelial neoplasia with adjacent atypia is associated with a higher incidence of cancer on subsequent needle biopsy than high-grade prostatic intraepithelial neoplasia alone. Urology. 2001;57:296–300.
   PubMed Web of Science ®Google Scholar
• Moore CK, Karikehalli S, Nazeer T, et al. Prognostic significance of high grade prostatic intraepithelial neoplasia and atypical small acinar proliferation in the contemporary era. J Urol. 2005;173:70–72.
   PubMed Web of Science ®Google Scholar
• Mian BM, Naya Y, Okihara K, et al. Predictors of cancer in repeat extended multisite prostate biopsy in men with previous negative extended multisite biopsy. Urology. 2002;60:836–840.
   PubMed Web of Science ®Google Scholar
• Halushka MK, Kahane H, Epstein JI. Negative 34betaE12 staining in a small focus of atypical glands on prostate needle biopsy: a follow-up study of 332 cases. Hum Pathol. 2004;35:43–46.
   PubMed Web of Science ®Google Scholar
• Park S, Shinohara K, Grossfeld GD, et al. Prostate cancer detection in men with prior high grade prostatic intraepithelial neoplasia or atypical prostate biopsy. J Urol. 2001;165:1409–1414.
   PubMed Web of Science ®Google Scholar
• O’dowd GJ, Miller MC, Orozco R, et al. Analysis of repeated biopsy results within 1 year after a noncancer diagnosis. Urology. 2000;55:553–559.
   PubMed Web of Science ®Google Scholar
• Postma R, Roobol M, Schroder FH, et al. Lesions predictive for prostate cancer in a screened population: first and second screening round findings. Prostate. 2004;61:260–266.
   PubMed Web of Science ®Google Scholar
• Hoedemaeker RF, Kranse R, Rietbergen JB, et al. Evaluation of prostate needle biopsies in a population-based screening study: the impact of borderline lesions. Cancer. 1999;85:145–152.
   PubMed Web of Science ®Google Scholar
• Amin MM, Jeyaganth S, Fahmy N, et al. Subsequent prostate cancer detection in patients with prostatic intraepithelial neoplasia or atypical small acinar proliferation. Can Urol Assoc J. 2007;1:245–249.
   PubMed Web of Science ®Google Scholar
• Mallén E, Gil P, Sancho C, et al. Atypical small acinar proliferation: review of a series of 64 patients. Scand J Urol Nephrol. 2006;40:272–275.
   PubMed Web of Science ®Google Scholar
• Mancuso PA, Chabert C, Chin P, et al. Prostate cancer detection in men with an initial diagnosis of atypical small acinar proliferation. BJU Int. 2007;99:49–52.
   PubMed Web of Science ®Google Scholar
• Schoenfield L, Jones JS, Zippe CD, et al. The incidence of high-grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancer. BJU Int. 2007;99:770–774.
   PubMed Web of Science ®Google Scholar
• Zuniga A, Lockwood G, Toi A, et al. Prostate specific antigen level is a predictor of cancer among men with high grade prostatic intraepithelial neoplasia but not among men with atypical small acinar proliferation [abstract]. J Urol. 2008;179:603.
   Web of Science ®Google Scholar
• Bostwick DG, Kochar P, Hossain D, et al. grade prostatic intraepithelial neoplasia and atypical small acinar proliferation are significant cancer risk factors: follow-up study of 1476 cases [abstract]. J Urol. 2009;181:752.
   Web of Science ®Google Scholar
• Schlesinger C, Bostwick DG, Iczkowski KA. High-grade prostatic intraepithelial neoplasia and atypical small acinar proliferation: predictive value for cancer in current practice. Am J Surg Pathol. 2005;29:1201–1207.
   PubMed Web of Science ®Google Scholar
• Korkes F, Mo SKG, de Jesus CSK, et al. Prostate biopsies containing prostate intraepithelial neoplasia and atypical small acinar proliferation: what to do? Einstein (Sao Paulo). 2009;7:411–414.
   Google Scholar
• Leite KR, Mitteldorf CA, Camara-Lopes LH. Repeat prostate biopsies following diagnoses of prostate intraepithelial neoplasia and atypical small gland proliferation. Int Braz J Urol. 2005;31:131–136.
   PubMedGoogle Scholar
• Girasole CR, Cookson MS, Putzi MJ, et al. Significance of atypical and suspicious small acinar proliferations, and high grade prostatic intraepithelial neoplasia on prostate biopsy: implications for cancer detection and biopsy strategy. J Urol. 2006;175:929–933.
   PubMed Web of Science ®Google Scholar
• Oh JW, Kim YB, Yang SO, et al. Prostate cancer detection rate of rebiopsy in patients with an initial diagnosis of atypical small acinar proliferation of the prostate. Korean J Urol. 2009;50:237–240.
   Google Scholar
• Ploussard G, Plennevaux G, Allory Y, et al. High-grade prostatic intraepithelial neoplasia and atypical small acinar proliferation on initial 21-core extended biopsy scheme: incidence and implications for patient care and surveillance. World J Urol. 2009;27:587–592.
   PubMed Web of Science ®Google Scholar
• Brimo F, Vollmer RT, Corcos J, et al. Outcome for repeated biopsy of the prostate: roles of serum PSA, small atypical glands, and prostatic intraepithelial neoplasia. Am J Clin Pathol. 2007;128:648–651.
   PubMed Web of Science ®Google Scholar
• Koca O, Cahskan S, Ozturk MI, et al. Significance of atypical small acinar proliferation and high-grade prostatic intraepithelial neoplasia in prostate biopsy. Korean J Urol. 2011;52:736–740.
   PubMedGoogle Scholar
• Lee KY, Choi Y, Lee K, et al. Atypical small acinar proliferation of prostate: follow-up study of 114 patients. Basic Appl Pathol. 2011;4:116–119.
   Google Scholar
• Ryu JH, Kim YB, Lee JK, et al. Predictive factors of prostate cancer at repeat biopsy in patients with an initial diagnosis of atypical small acinar proliferation of the prostate. Korean J Urol. 2010;51:752–756.
   PubMedGoogle Scholar
• Aglamis E, Kocaarslan R, Yucetas U, et al. How many cores should be taken in a repeat biopsy on patients in whom atypical small acinar proliferation has been identified in an initial transrectal prostate biopsy? Int Braz J Urol. 2014;40:605–612.
   PubMed Web of Science ®Google Scholar
• Kopp RP, Parsons JK, Shiau J, et al. Prostate atypia: clinical and pathological variables associated with cancer diagnosis on repeat biopsy. Prostate Cancer Prostatic Dis. 2011;14:149–154.
   PubMed Web of Science ®Google Scholar
• Leone A, Rotker K, Butler C, et al. Atypical small acinar proliferation: repeat biopsy and detection of high grade prostate cancer. Prostate Cancer. 2015;2015:810159.
   PubMed Web of Science ®Google Scholar
• Laurila M, van der Kwast T, Bubendorf L, et al. Detection rates of cancer, high grade PIN and atypical lesions suspicious for cancer in the European Randomized Study of Screening for Prostate Cancer. Eur J Cancer. 2010;46:3068–3072.
   PubMed Web of Science ®Google Scholar
• Leone A, Gershman B, Rotker K, et al. Atypical small acinar proliferation (ASAP): is a repeat biopsy necessary ASAP? A multi-institutional review. Prostate Cancer Prostatic Dis. 2016;19:68–71.
   PubMed Web of Science ®Google Scholar
• Raskolnikov D, Rais-Bahrami S, George AK, et al. The role of image guided biopsy targeting in patients with atypical small acinar proliferation. J Urol. 2015;193:473–478.
   PubMed Web of Science ®Google Scholar
• Dorin RP, Wiener S, Harris CD, et al. Prostate atypia: does repeat biopsy detect clinically significant prostate cancer? Prostate. 2015;75:673–678.
   PubMed Web of Science ®Google Scholar
• Warlick C, Feia K, Tomasini J, et al. Rate of Gleason 7 or higher prostate cancer on repeat biopsy after a diagnosis of atypical small acinar proliferation. Prostate Cancer Prostatic Dis. 2015;18:255–259.
   PubMed Web of Science ®Google Scholar
• Merrimen JL, Jones G, Hussein SA, et al. A model to predict prostate cancer after atypical findings in initial prostate needle biopsy. J Urol. 2011;185:1240–1245.
   PubMed Web of Science ®Google Scholar
• Mearini L, Costantini E, Bellezza G, et al. Is there any clinical parameter able to predict prostate cancer after initial diagnosis of atypical small acinar proliferation? Urol Int. 2008;81:29–35.
   PubMed Web of Science ®Google Scholar
• Kim TS, Ko KJ, Shin SJ, et al. Multiple cores of high grade prostatic intraepithelial neoplasia and any core of atypia on first biopsy are significant predictor for cancer detection at a repeat biopsy. Korean J Urol. 2015;56:796–802.
   PubMedGoogle Scholar
• Keetch DW, Catalona WJ, Smith DS. Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values. J Urol. 1994;151:1571–1574.
   PubMed Web of Science ®Google Scholar
• Adamczyk P, Wolski Z, Butkiewicz R, et al. Significance of atypical small acinar proliferation and extensive high-grade prostatic intraepithelial neoplasm in clinical practice. Cent European J Urol. 2014;67:136–141.
   PubMedGoogle Scholar
• Bostanci Y, Ozden E, Yakupoglu YK, et al. What is the fate of repeat biopsies after diagnosis of high grade prostatic intraepithelial neoplasia and atypical small acinar proliferation? J Exp Clin Med. 2013;30:241–245.
   Google Scholar
• Ericson KJ, Wenger HC, Rosen AM, et al. Prostate cancer detection following diagnosis of atypical small acinar proliferation. Can J Urol. 2017;24:8714–8720.
   PubMed Web of Science ®Google Scholar
• Chen YB, Pierorazio PM, Epstein JI. Initial atypical diagnosis with carcinoma on subsequent prostate needle biopsy: findings at radical prostatectomy. J Urol. 2010;184:1953–1957.
   PubMed Web of Science ®Google Scholar
• Karakiewicz PI, Benayoun S, Bégin LR, et al. Chronic inflammation is negatively associated with prostate cancer and high-grade prostatic intraepithelial neoplasia on needle biopsy. Int J Clin Pract. 2007;61:425–430.
   PubMed Web of Science ®Google Scholar
• Cormio L, Lucarelli G, Selvaggio O, et al. Absence of bladder outlet obstruction is an independent risk factor for prostate cancer in men undergoing prostate biopsy. Medicine (Baltimore). 2016;95:e2551.
   PubMed Web of Science ®Google Scholar
• Cormio L, Lucarelli G, Netti GS, et al. Post-void residual urinary volume is an independent predictor of biopsy results in men at risk for prostate cancer. Anticancer Res. 2015;35:2175–2182.
   PubMed Web of Science ®Google Scholar
• Kronz JD, Shaikh AA, Epstein JI. High-grade prostatic intraepithelial neoplasia with adjacent small atypical glands on prostate biopsy. Hum Pathol. 2001;32:389–395.
   PubMed Web of Science ®Google Scholar
• Roscigno M, Scattoni V, Freschi M, et al. Monofocal and plurifocal high-grade prostatic intraepithelial neoplasia on extended prostate biopsies: factors predicting cancer detection on extended repeat biopsy. Urology. 2004;63:1105–1110.
   PubMed Web of Science ®Google Scholar
• Qian J, Jenkins RB, Bostwick DG. Genetic and chromosomal alterations in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization. Eur Urol. 1999;35:479–483.
   PubMed Web of Science ®Google Scholar
• Levine MA, Ittman M, Melamed J, et al. Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer. J Urol. 1998;159:471–475.
   PubMed Web of Science ®Google Scholar
• Ficarra V, Novella G, Novara G, et al. The potential impact of prostate volume in the planning of optimal number of cores in the systematic transperineal prostate biopsy. Eur Urol. 2005;48:932–937.
   PubMed Web of Science ®Google Scholar
• Chun FKH, Epstein JI, Ficarra V, et al. Optimizing performance and interpretation of prostate biopsy: a critical analysis of the literature. Eur Urol. 2010;58:851–864.
   PubMed Web of Science ®Google Scholar
• Destefanis P, Bosio A, De Maria C, et al. Targeted needle re-biopsy of the prostate after combination of endorectal MRI (ENDOMRI) and magnetic resonance spectroscopy (MRS) in patients with atypical small acinar proliferation (ASAP) [abstract]. Eur Urol Suppl. 2009;8:354.
   Web of Science ®Google Scholar
• Rais-Bahrami S, Siddiqui MM, Turkbey B, et al. Utility of multiparametric magnetic resonance imaging suspicion levels for detecting prostate cancer. J Urol. 2013;190:1721–1727.
   PubMed Web of Science ®Google Scholar
• Siddiqui MM, Rais-Bahrami S, Truong H, et al. Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy. Eur Urol. 2013;64:713–719.
   PubMed Web of Science ®Google Scholar
• Rais-Bahrami S, Turkbey B, Rastinehad AR, et al. Natural history of small index lesions suspicious for prostate cancer on multiparametric MRI: recommendations for interval imaging follow-up. Diagn Interv Radiol. 2014;20:293–298.
   PubMed Web of Science ®Google Scholar
• Cool DW, Romagnoli C, Izawa JI, et al. Comparison of prostate MRI-3D transrectal ultrasound fusion biopsy for first-time and repeat biopsy patients with previous atypical small acinar proliferation. Can Urol Assoc J. 2016;10:342–348.
   PubMed Web of Science ®Google Scholar
• Cramer SF. Sampling ‘error’ [letter]. CAP Today. 1997;11:10.
   PubMedGoogle Scholar
• Stewart CS, Leibovich BC, Weaver AL, et al. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. J Urol. 2001;166:86–91.
   PubMed Web of Science ®Google Scholar
• Pepe P, Aragona F. Saturation prostate needle biopsy and prostate cancer detection at initial and repeat evaluation. Urology. 2007;70:1131–1135.
   PubMed Web of Science ®Google Scholar
• El-Hakim A, Moussa S. CUA guidelines on prostate biopsy methodology. Can Urol Assoc J. 2010;4:89–94.
   PubMed Web of Science ®Google Scholar
• Borboroglu PG, Comer SW, Riffenburgh RH, et al. Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies. J Urol. 2000;163:158–162.
   PubMed Web of Science ®Google Scholar
• Renshaw AA, Richie JP, Loughlin KR, et al. Maximum diameter of prostatic carcinoma is a simple inexpensive, and independent predictor of prostate-specific antigen failure in radical prostatectomy specimens. Validation in a cohort of 434 patients. Am J Clin Pathol. 1999;111:641–644.
   PubMed Web of Science ®Google Scholar
• Kamoi K, Troncoso P, Babaian RJ. Strategy for repeat biopsy in patients with high grade prostatic intraepithelial neoplasia. J Urol. 2000;163:819–823.
   PubMed Web of Science ®Google Scholar
• Scattoni V, Raber M, Capitanio U, et al. The optimal rebiopsy prostatic scheme depends on patient clinical characteristics: results of a recursive partitioning analysis based on a 24-core systematic scheme. Eur Urol. 2011;60:834–841.
   PubMed Web of Science ®Google Scholar
• Vis AN, Hoedemaeker RF, Roobol M, et al. The predictive value for prostate cancer of lesions that raise suspicion of concomitant carcinoma: an evaluation from a randomized, population-based study of screening for prostate cancer. Cancer. 2001;92:524–534.
   PubMed Web of Science ®Google Scholar
• Zhou M, Magi-Galluzzi C. Clinicopathological features of prostate cancers detected after an initial diagnosis of ‘atypical glands suspicious for cancer’. Pathology. 2010;42:334–338.
   PubMed Web of Science ®Google Scholar
• Byun SS, Lee S, Lee SE, et al. Recent changes in the clinicopathologic features of Korean men with prostate cancer: a comparison with Western populations. Yonsei Med J. 2012;53:543–549.
   PubMed Web of Science ®Google Scholar
• Zaytoun OM, Jones JS. Prostate cancer detection after a negative prostate biopsy: lessons learnt in the Cleveland Clinic experience. Int J Urol. 2011;18:557–568.
   PubMed Web of Science ®Google Scholar